Peripheral Vascular Devices Market Analysis, Size, Trends | Europe | 2020-2026 | MedSuite

Peripheral Vascular Devices Market Analysis, Size, Trends | Europe | 2020-2026 | MedSuite

0

  • Year: 2020
  • Scope: 2016-2026
  • Region: Europe
  • Published Date: 04/28/2020
  • Pages: 914
  • Type: MedSuite

Throughout this medical market research, we analyzed 65 peripheral vascular companies across Europe and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.

While this MedSuite report contains all the EU Peripheral Vascular Devices market data and analysis, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.

Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Forecasts Until 2026, and Historical Data to 2016
  • Market Drivers & Limiters for Each Peripheral Vascular Device market
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Peripheral Vascular Procedure Volumes
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors
  • Related Press Releases from Top Competitors

Market Value and Industry Trends

The European peripheral vascular device market was valued at about €1.3 billion in 2019. This is expected to increase over the forecast period at a CAGR of 2.9% to reach about €1.6 billion by 2026. There were around 1.15 million peripheral vascular procedures performed.

A meta-analysis by Katsanos, published in the Journal of the American Heart Association in December 2018, demonstrated a late-mortality signal from paclitaxel use in the peripheries. In response, the Food and Drug Administration in the United States issued a statement in January 2019 that it would investigate the efficacy of these devices. This statement had a worldwide impact on physicians’ practices, which resulted in a large negative shock to both drug-coated balloons and drug-eluting stents, the majority of which use paclitaxel coatings.

Peripheral Vascular Market Value Growth

The growth of venous treatments in Europe is expected to accelerate in the coming years as clinical knowledge continues to develop and expertise in the medical community is diffused. While currently consolidated within select regions in the United Kingdom, Germany, France, Austria and Switzerland, venous treatment centres are expected to be developed across Europe to facilitate both the diagnosis and treatment of venous disease.

Treatment of peripheral arterial disease is slowly continuing to increase its penetration in the treatable population. As Europe continues to age, the total number of procedures is expected to grow over the forecast period. As reimbursement tensions continue, treatment techniques have continued to be refined towards the most cost effective, long-term option for patients.

Competitive Analysis

Leading Competitors in the EU Peripheral Vascular MarketThe market leader in Europe during 2019 was Medtronic. Due to its strong presence within the Stent Graft market, and its broad product portfolio, Medtronic secured large shares of the high-value markets. This has also given market power to the company to bundle its less expensive products together, increasing its total market presence. Medtronic’s most notable products in this market include the Admiral IN.PACT™ drug-coated balloons, and its array of Endurant™ and Valiant™ stent grafts, although the broader portfolio of stents and PTA balloons also generate significant revenue for the company.

Boston Scientific, following the merger with BTG in 2019, became the second-leading competitor in the European market. The company has impressively developed its venous treatment and transcatheter embolization portfolios following the acquisition and secured the leading position in both markets.

Cook Medical was able to secure the third-leading position in the peripheral vascular market, largely due to the company’s strong presence in the stent graft market. Cook Medical led the IVCF market, though it is not a significant revenue generator for the company, due to the small market size.

Report Regional Coverage

Throughout this research series, iData Research has covered several countries in great detail. Each country may be purchased as a stand-alone report, tailoring the data to your needs. The countries covered are:

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Benelux (Belgium, Netherlands, and Luxembourg)
  • Switzerland
  • Austria
  • Portugal
  • Scandinavia

Segments Covered

Feel free to click on any of the segments below to view detailed market segmentation.

  • Procedure Numbers for Peripheral Vascular market – MedPro – Discusses peripheral vascular procedure volumes performed for each segment of the European market.
  • Peripheral Arterial Stent Market – MedCore – This market is comprised of the markets for bare-metal Stents, covered stents, disposables, and drug eluting stents.
  • Peripheral Venous Stent Market – MedCore – In-depth analysis of the Angioplasty Market.
  • PTA Balloons Market – MedCore – This market is comprised of the markets for standard PTA balloon, high pressure PTA balloon, large PTA balloon, small PTA balloon and specialty PTA balloon.
  • Atherectomy Device Market – MedCore – In-depth analysis of the Atherectomy Device Market.
  • CTO Market – MedCore – In-depth analysis of the CTO market. The chapter includes Recanalization CTO device market and Re-Entry CTO Device market.
  • Embolic Protection Device Market – MedCore – In-depth analysis of the Embolic Protection Device Market.
  • Stent Grafts Market – MedCore – In-depth analysis of the stent graft market. The chapter includes market segments, such as the AAA stent graft market, TAA stent graft market, and fenestrated stent graft.
  • Surgical Stent Grafts Market – MedCore – In-depth analysis of the surgical stent graft market. The chapter includes market segments, such as the lower limb surgical graft market, AV access surgical graft market, aorta surgical graft market, and extra-anatomical surgical graft market.
  • AV Access Thrombectomy Device Market – MedCore – In-depth analysis of the AV Access Thrombectomy Device Market.
  • Inferior Vena Cava Filter Market – MedCore – In-depth analysis of the Inferior Vena Cava Filter Market.
  • Diagnostic and Interventional Catheter Market – MedCore – This market is comprised of the markets for diagnostic catheters, and interventional catheters.
  • Diagnostic and Interventional Guidewire Market- MedCore – This market is comprised of the markets for standard and hydrophilic guidewires.
  • Introducer Sheaths Market – MedCore – In-depth analysis of the Introducer Sheath Market.
  • Vascular Closure Device Market – MedCore – In-depth analysis of the vascular closure device market. The chapter includes market segments, such as the Invasive VCD market, and Non-invasive VCD market .
  • Transcatheter Embolization Device Market – MedCore – The chapter includes market segments,s uch as the particle embolization device market, coil embolization device market, and liquid embolization device market.

Detailed Market Segmentation



 

DON’T SEE THE SEGMENT OR DATA YOU NEED?

Feel free to contact us or send a request by pressing one of the buttons below.

For a Full Table of Contents, please contact iData.

Table Of Content for the European Peripheral Vascular Report

TABLE OF CONTENTS I
LIST OF FIGURES XVII
LIST OF CHARTS XLIII
EXECUTIVE SUMMARY 1
EUROPEAN MARKET FOR PERIPHERAL VASCULAR DEVICES OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 9
MARKET DEVELOPMENTS 13
PROCEDURE NUMBERS 14
MARKETS INCLUDED 16
VERSION HISTORY 18

RESEARCH METHODOLOGY 19


Step 1: Project Initiation & Team Selection 19
Step 2: Prepare Data Systems and Perform Secondary Research 22
Step 3: Preparation for Interviews & Questionnaire Design 24
Step 4: Performing Primary Research 25
Step 5: Research Analysis: Establishing Baseline Estimates 27
Step 6: Market Forecast and Analysis 28
Step 7: Identify Strategic Opportunities 30
Step 8: Final Review and Market Release 31
Step 9: Customer Feedback and Market Monitoring 32

DISEASE OVERVIEW 33


2.1 BASIC ANATOMY 33
2.2 DISEASE TREATMENTS & DIAGNaOSTICS 34
2.2.1 Aortic Aneurysms 34
2.2.2 Atherosclerosis 35
2.2.3 Peripheral Arterial Disease (PAD) 36
2.2.4 Deep Vein Thrombosis (DVT) 37
2.2.5 Pulmonary Embolism (PE) 38
2.3 PATIENT DEMOGRAPHICS 40
2.3.1 Aortic Aneurysms 40
2.3.2 Atherosclerosis 40
2.3.3 Peripheral Arterial Disease (PAD) 40
2.3.4 Deep Vein Thrombosis (DVT) 41
2.3.5 Pulmonary Embolism (PE) 41

PRODUCT PORTFOLIO 43


3.1 INTRODUCTION 43
3.2 PRODUCT PORTFOLIOS 43
3.2.1 Peripheral Vascular Stent 43
3.2.2 Venous Stent 46
3.2.3 Percutaneous Transluminal Angioplasty (PTA) Balloon 47
3.2.4 Drug-Coated Balloon 51
3.2.5 Atherectomy Device 53
3.2.6 Chronic Total Occlusion (CTO) Device 55
3.2.7 Intravascular Lithotripsy 57
3.2.8 Surgical Graft 58
3.2.9 Stent Graft 61
3.2.10 Embolic Protection Device 63
3.2.11 Peripheral Thrombus Management Device 65
3.2.12 Inferior Vena Cava Filter 68
3.2.13 Carotid Shunt 69
3.2.14 Diagnostic and Interventional Catheters 70
3.2.15 Diagnostic and Interventional Guidewire 73
3.2.16 Introducer Sheath 77
3.2.17 Vascular Closure Device (VCD) 81
3.2.18 Transcatheter Embolization Device 83
3.2.19 Peripheral IVUS Catheter 86
3.3 REGULATORY ISSUES AND RECALLS 87
3.3.1 Abbott 87
3.3.1.1 Carotid Shunt 87
3.3.1.2 Vascular Closure Device 87
3.3.2 Argon Medical 88
3.3.2.1 Introducer Sheaths 88
3.3.3 Arrow International 89
3.3.3.1 Introducer Sheaths 89
3.3.4 Atrium Medical 91
3.3.4.1 Peripheral Vascular Stent 91
3.3.5 BD 92
3.3.5.1 Inferior Vena Cava Filter 92
3.3.5.2 Introducer Sheaths 92
3.3.5.3 Stent Graft 93
3.3.6 Boston Scientific 94
3.3.6.1 Atherectomy Devices 94
3.3.6.2 Diagnostic and Interventional Catheters 95
3.3.6.3 Introducer Sheaths 96
3.3.6.4 Peripheral Thrombus Management Devices 97
3.3.7 Cardinal Health 98
3.3.7.1 Vascular Closure Devices 98
3.3.8 Cardiovascular System (C.S.I.) 99
3.3.8.1 Atherectomy Devices 99
3.3.9 Cook Medical 101
3.3.9.1 Diagnostic and Interventional Catheters 101
3.3.9.2 Introducer Sheaths 101
3.3.9.3 Inferior Vena Cava Filters 102
3.3.9.4 Peripheral Vascular Stents 103
3.3.9.5 Stent Grafts 103
3.3.10 Cordis (Cardinal Health) 104
3.3.10.1 Diagnostic and Interventional Catheters 104
3.3.10.2 Inferior Vena Cava Filters 104
3.3.10.3 Peripheral Stents 105
3.3.11 Endologix 106
3.3.11.1 Stent Grafts 106
3.3.12 Edwards Lifesciences 108
3.3.12.1 Chronic Total Occlusion Devices 108
3.3.13 Maquet 109
3.3.13.1 PTA Balloons 109
3.3.14 Medtronic 110
3.3.14.1 Carotid Shunts 110
3.3.14.2 Diagnostic and Interventional Catheters 110
3.3.14.3 PTA Balloon Catheters 110
3.3.14.4 Peripheral Stents 112
3.3.14.5 Stent Grafts 112
3.3.14.6 Transcatheter Embolization Devices 113
3.3.15 Spectranetics (Philips) 114
3.3.15.1 Atherectomy Devices 114
3.3.15.2 Chronic Total Occlusion Devices 115
3.3.16 Shockwave Medical, Inc. 116
3.3.16.1 Intravascular Lithotripsy 116
3.3.17 Terumo 117
3.3.17.1 Introducer Sheaths 117
3.3.17.2 PTA Balloon Catheters 117
3.3.18 Other Companies 117
3.3.18.1 Atherectomy Devices 117
3.3.18.2 Introducer Sheaths 118
3.3.18.3 PTA Balloon Catheters 118
3.3.18.4 Peripheral IVUS Catheters 119
3.3.18.5 Stent Grafts 119
3.3.18.6 Vascular Closure Devices (VCD) 120
3.4 CLINICAL TRIALS 121
3.4.1 Abbott 121
3.4.1.1 Peripheral Vascular Stent 121
3.4.1.2 Other Peripheral Vascular Related Studies 124
3.4.2 B. Braun 125
3.4.2.1 Diagnostic and Interventional Catheters 125
3.4.2.2 Peripheral Vascular Stent 125
3.4.3 Boston Scientific 126
3.4.3.1 Atherectomy Devices 126
3.4.3.2 Drug-Coated Balloons 127
3.4.3.3 Peripheral Vascular Stents 129
3.4.3.4 Other Peripheral Vascular Related Studies 130
3.4.3.5 Venous Stents 130
3.4.4 C.R. Bard (BD) 131
3.4.4.1 Diagnostic and Interventional Catheters 131
3.4.4.2 Drug-Coated Balloons 131
3.4.4.3 Venous Stents 133
3.4.4.4 Other Peripheral Vascular Related Studies 134
3.4.5 Cardinal Health 135
3.4.5.1 Other Peripheral Vascular Related Studies 135
3.4.6 Cook Medical 136
3.4.6.1 Drug-Eluting Stents 136
3.4.6.2 Inferior Vena Cava Filters 137
3.4.6.3 Peripheral Vascular Stents 138
3.4.6.4 Venous Stents 139
3.4.7 Cordis (Cardinal Health) 140
3.4.7.1 Peripheral Vascular Stents 140
3.4.8 Medtronic 141
3.4.8.1 Atherectomy Devices 141
3.4.8.2 Drug-Coated Balloons 142
3.4.8.3 Other Peripheral Vascular Related Studies 148
3.4.9 Merit Medical 150
3.4.9.1 Stent Grafts 150
3.4.10 Philips/Spectranetics 151
3.4.10.1 Atherectomy Devices 151
3.4.10.2 Peripheral IVUS Catheters 151
3.4.10.3 Spectranetics 152
3.4.10.3.1 Drug-Coated Balloons 152
3.4.10.3.2 Atherectomy Devices 155
3.4.11 Shockwave Medical, Inc. 156
3.4.11.1 Lithoplasty System 156
3.4.12 Surmodics 157
3.4.12.1 Drug-Coated Balloons 157
3.4.13 Terumo 158
3.4.13.1 Drug-Coated Balloons 158
3.4.13.2 Peripheral Vascular Stents 158
3.4.14 W.L. Gore 159
3.4.14.1 Peripheral Vascular Stents 159
3.4.14.2 Stent Grafts 160
3.4.14.3 Expandable Balloons 161
3.4.15 Other Companies 162
3.4.15.1 Carotid Shunt / Endarterectomy 162
3.4.15.2 Drug-Coated Balloons 163
3.4.15.3 Peripheral Vascular Stents 167
3.4.15.4 Other Peripheral Vascular Related Studies 170

PERIPHERAL VASCULAR DEVICE MARKET OVERVIEW 171


4.1 INTRODUCTION 171
4.1.1 Atherosclerosis 171
4.1.2 Peripheral Arterial Disease (PAD) 172
4.2 CURRENCY EXCHANGE RATE 173
4.3 MARKET OVERVIEW 174
4.4 TREND ANALYSIS 182
4.5 DRIVERS AND LIMITERS 186
4.5.1 Market Drivers 186
4.5.2 Market Limiters 187
4.6 COMPETITIVE MARKET SHARE ANALYSIS 189

COMPANY PROFILES 197


4.7.1 Abbott 197
4.7.2 Becton Dickinson (BD) 198
4.7.3 Boston Scientific 199
4.7.4 Cardinal Health 200
4.7.4.1 Cordis (Cardinal Health) 200
4.7.5 Cook Medical 201
4.7.6 Maquet 202
4.7.7 Medtronic 203
4.7.8 Teleflex 205
4.7.9 Terumo Interventional System (TIS) 206
4.7.10 W.L. Gore 207
4.8 SWOT ANALYSIS 208
4.8.1 Abbott 209
4.8.2 B. Braun 210
4.8.3 Boston Scientific 211
4.8.4 BD 212
4.8.5 Cardinal Health 213
4.8.6 Cook Medical 214
4.8.7 Integra Lifesciences 215
4.8.8 Maquet 216
4.8.9 Medtronic 217
4.8.10 Merit Medical 218
4.8.11 Phillips 219
4.8.12 Teleflex 220
4.8.13 Terumo 221
4.8.14 W.L. Gore 222
4.9 MERGERS AND ACQUISITIONS 223

COUNTRY PROFILES 228


5.1 INTRODUCTION 228
5.1.1.1 Population 228
5.1.1.2 Median Age 228
5.1.1.3 GDP Per Capita 228
5.1.1.4 Price Index 228
5.2 GERMANY 229
5.3 FRANCE 230
5.4 UNITED KINGDOM 231
5.5 ITALY 232
5.6 SPAIN 233
5.7 BENELUX 234
5.8 SCANDINAVIA 235
5.9 AUSTRIA 236
5.10 SWITZERLAND 237
5.11 PORTUGAL 238

PROCEDURE NUMBERS 239

6.1 PROCEDURES 239
6.1.1 Total Procedures 239
6.1.2 Bare Metal Stent Procedures 241
6.1.2.1 Iliac Bare Metal Stent Procedures 246
6.1.2.2 Femoral Popliteal Bare Metal Stent Procedures 247
6.1.2.3 Infra-Popliteal Bare Metal Stent Procedures 248
6.1.2.4 Renal Bare Metal Stent Procedures 249
6.1.2.5 Carotid Bare Metal Stent Procedures 250
6.1.3 Venous Stenting Procedures 251
6.1.4 Angioplasty Procedures 253
6.1.5 Atherectomy Procedures 255
6.1.6 Chronic Total Occlusion Procedures 257
6.1.7 Embolic Protection Device Procedures 258
6.1.8 Stent Graft Procedures 260
6.1.8.1 AAA Stent Graft Procedures 261
6.1.8.2 TAA Stent Graft Procedures 262
6.1.8.3 Fenestrated Stent Graft Procedures 263
6.1.9 Surgical Graft Procedures 264
6.1.9.1 Lower Limb Surgical Graft Procedures 265
6.1.9.2 AV Access Surgical Graft Procedures 266
6.1.9.3 Aorta Repair Surgical Graft Procedures 267
6.1.9.3.1 AAA Surgical Graft Procedures 269
6.1.9.3.2 TAA Surgical Graft Procedures 270
6.1.9.4 Extra-Anatomical Surgical Graft Procedures 271
6.1.10 AV Access Thrombectomy Procedures 272
6.1.13.2 Coil Embolization Procedures 289
6.1.13.3 Liquid Embolization Procedures 290
6.1.14 Drug-Coated Balloon Procedures 291
6.1.16 Lithotripsy Procedures 293
6.1.17 IVUS Procedures 294

PERIPHERAL ARTERIAL STENT MARKET 295


7.1 INTRODUCTION 295
7.1.1 Off-Label Use 296
7.1.2 Covered Stents 296
7.1.3 Drug-Eluting Stents 297
7.1.4 Stent Length 298
7.2 MARKET OVERVIEW 300
7.3 MARKET ANALYSIS AND FORECAST 306
7.3.1 Total Peripheral Arterial Stent Market 306
7.3.2 Total Bare-Metal Stent Market 314
7.3.2.1 Bare-Metal Illiac Stent Market 324
7.3.2.2 Bare-Metal Femoral-Popliteal Stent Market 331
7.3.2.3 Bare-Metal Infra-Popliteal Market 338
7.3.2.4 Bare-Metal Renal Stent Market 345
7.3.2.5 Bare-Metal Carotid Stent Market 352
7.3.2.6 Total Bare-Metal Stent Unit Analysis by Indication 359
7.3.3 Covered Stent Market 367
7.3.4 Drug-Eluting Stent Market 374
7.4 DRIVERS AND LIMITERS 382
7.4.1 Market Drivers 382
7.4.2 Market Limiters 383
7.5 COMPETITIVE MARKET SHARE ANALYSIS 385

PERIPHERAL VENOUS STENT MARKET 390


8.1 INTRODUCTION 390
8.2 MARKET ANALYSIS AND FORECAST 392
8.3 DRIVERS AND LIMITERS 400
8.3.1 Market Drivers 400
8.3.2 Market Limiters 400
8.4 COMPETITIVE MARKET SHARE ANALYSIS 402

PTA BALLOON CATHETER MARKET 405


9.1 INTRODUCTION 405
9.1.1 Types of PTA Balloon Catheters 405
9.2 MARKET OVERVIEW 407
9.3 MARKET ANALYSIS AND FORECAST 413
9.3.1 Total PTA Balloon Catheter Market 413
9.3.2 Standard PTA Balloon Catheter Market 420
9.3.3 High-Pressure PTA Balloon Catheter Market 427
9.3.4 Large PTA Balloon Catheter Market 434
9.3.5 Small PTA Balloon Catheter Market 441
9.3.6 Specialty PTA Balloon Catheter Market 448
9.4 DRIVERS AND LIMITERS 450
9.4.1 Market Drivers 450
9.4.2 Market Limiters 451
9.5 COMPETITIVE MARKET SHARE ANALYSIS 452

ATHERECTOMY DEVICE MARKET 457


10.1 INTRODUCTION 457
10.2 MARKET ANALYSIS AND FORECAST 459
10.3 DRIVERS AND LIMITERS 467
10.3.1 Market Drivers 467
10.3.2 Market Limiters 468
10.4 COMPETITIVE MARKET SHARE ANALYSIS 470

CHRONIC TOTAL OCCLUSION DEVICE MARKET 475


11.1 INTRODUCTION 475
11.2 MARKET OVERVIEW 476
11.3 MARKET ANALYSIS AND FORECAST 481
11.3.1 Total Chronic Total Occlusion (CTO) Device Market 481
11.3.2 Recanalization CTO Device Market 483
11.3.3 Re-Entry CTO Device Market 485
11.4 DRIVERS AND LIMITERS 487
11.4.1 Market Drivers 487
11.4.2 Market Limiters 488
11.5 COMPETITIVE MARKET SHARE ANALYSIS 489

EMBOLIC PROTECTION DEVICE MARKET 492


12.1 INTRODUCTION 492
12.1.1 Protection Mechanism 492
12.1.1.1 Filter Basket 492
12.1.1.2 Distal Balloon Occlusion 493
12.1.1.3 Flow Redirection 493
12.2 MARKET ANALYSIS AND FORECAST 494
12.3 DRIVERS AND LIMITERS 501
12.3.1 Market Drivers 501
12.3.2 Market Limiters 501
12.4 COMPETITIVE MARKET SHARE ANALYSIS 503

STENT GRAFT MARKET 506


13.1 INTRODUCTION 506
13.2 MARKET OVERVIEW 507
13.3 MARKET ANALYSIS AND FORECAST 512
13.3.1 Total Stent Graft Market 512
13.3.2 AAA Stent Graft Market 520
13.3.3 TAA Stent Graft Market 527
13.3.4 Fenestrated Stent Graft 534
13.4 DRIVERS AND LIMITERS 542
13.4.1 Market Drivers 542
13.4.2 Market Limiters 543
13.5 COMPETITIVE MARKET SHARE ANALYSIS 545

SURGICAL GRAFT MARKET 550


14.1 INTRODUCTION 550
14.2 MARKET OVERVIEW 551
14.3 MARKET ANALYSIS AND FORECAST 556
14.3.1 Total Surgical Graft Market 556
14.3.2 Lower Limb Surgical Graft Market 563
14.3.3 AV Access Surgical Graft Market 570
14.3.4 Total Aorta Repair Surgical Graft Market 577
14.3.4.1 AAA Surgical Graft Market 587
14.3.4.2 TAA Surgical Graft Market 594
14.3.5 Extra-Anatomical Surgical Graft Market 601
14.4 DRIVERS AND LIMITERS 608
14.4.1 Market Drivers 608
14.4.2 Market Limiters 609
14.5 COMPETITIVE MARKET SHARE ANALYSIS 611

AV ACCESS THROMBECTOMY DEVICE MARKET 615


15.1 INTRODUCTION 615
15.1.1 Other Peripheral Applications of Thrombectomy Devices 615
15.2 MARKET ANALYSIS AND FORECAST 617
15.3 DRIVERS AND LIMITERS 624
15.3.1 Market Drivers 624
15.3.2 Market Limiters 624
15.4 COMPETITIVE MARKET SHARE ANALYSIS 626

INFERIOR VENA CAVA FILTER MARKET 629


16.1 INTRODUCTION 629
16.2 MARKET ANALYSIS AND FORECAST 631
16.3 DRIVERS AND LIMITERS 638
16.3.1 Market Drivers 638
16.3.2 Market Limiters 638
16.4 COMPETITIVE MARKET SHARE ANALYSIS 640

DIAGNOSTIC AND INTERVENTIONAL CATHETER MARKET 644


17.1 INTRODUCTION 644
17.2 MARKET OVERVIEW 645
17.3 MARKET ANALYSIS AND FORECAST 650
17.3.1 Total Diagnostic and Interventional Catheter Market 650
17.3.2 Diagnostic Catheter Market 657
17.3.3 Interventional Catheter Market 664
17.4 DRIVERS AND LIMITERS 671
17.4.1 Market Drivers 671
17.4.2 Market Limiters 672
17.5 COMPETITIVE MARKET SHARE ANALYSIS 674

STANDARD AND HYDROPHILIC GUIDEWIRE MARKET 678


18.1 INTRODUCTION 678
18.2 MARKET OVERVIEW 679
18.3 MARKET ANALYSIS AND FORECAST 684
18.3.1 Total Standard and Hydrophilic Guidewire Market 684
18.3.2 Standard Guidewire Market 691
18.3.3 Hydrophilic Guidewire Market 698
18.4 DRIVERS AND LIMITERS 705
18.4.1 Market Drivers 705
18.4.2 Market Limiters 705
18.5 COMPETITIVE MARKET SHARE ANALYSIS 708

INTRODUCER SHEATH MARKET 712


19.1 INTRODUCTION 712
19.2 MARKET ANALYSIS AND FORECAST 713
19.3 DRIVERS AND LIMITERS 720
19.3.1 Market Drivers 720
19.3.2 Market Limiters 720
19.4 COMPETITIVE MARKET SHARE ANALYSIS 722

VASCULAR CLOSURE DEVICE MARKET 725


20.1 INTRODUCTION 725
20.2 MARKET OVERVIEW 727
20.2.1 Vascular Closure Device Market Overview by Device Type 727
20.2.2 Vascular Closure Device Market Overview by Approach 732
20.3 MARKET ANALYSIS AND FORECAST 737
20.3.1 Total Vascular Closure Device Market 737
20.3.2 Vascular Closure Device Market by Device Type 744
20.3.2.1 Invasive VCD Market 744
20.3.2.1.1 Small Bore Invasive VCD Market 754
20.3.2.1.2 Large Bore Invasive VCD Market 761
20.3.2.2 Non-Invasive VCD Market 769
20.3.3 Vascular Closure Device Market by Approach 776
20.3.3.1 Femoral VCD Market 778
20.3.3.2 Radial VCD Market 785
20.4 DRIVERS AND LIMITERS 792
20.4.1 Market Drivers 792
20.4.2 Market Limiters 793
20.5 COMPETITIVE MARKET SHARE ANALYSIS 795

TRANSCATHETER EMBOLIZATION DEVICE MARKET 799


21.1 INTRODUCTION 799
21.1.1 Particle Embolic Devices 799
21.1.2 Coil Embolic Devices 800
21.1.3 Liquid Embolic Devices 800
21.2 MARKET OVERVIEW 802
21.3 MARKET ANALYSIS AND FORECAST 807
21.3.1 Particle Embolic Device Market 807
21.3.2 Coil Embolic Device Market 816
21.3.3 Liquid Embolic Device Market 824
21.4 DRIVERS AND LIMITERS 831
21.4.1 Market Drivers 831
21.4.2 Market Limiters 831
21.5 COMPETITIVE MARKET SHARE ANALYSIS 834

APPENDIX I: DRUG-COATED BALLOON CATHETER MARKET 839


22.1 MARKET ANALYSIS AND FORECAST 839
22.2 DRIVERS AND LIMITERS 848
22.2.1 Market Drivers 848
22.2.2 Market Limiters 848

APPENDIX II: INTRAVASCULAR LITHOTRIPSY MARKET 849


23.1 INTRODUCTION 849
23.2 MARKET ANALYSIS AND FORECAST 851
23.3 DRIVERS AND LIMITERS 853
23.3.1 Market Drivers 853
23.3.2 Market Limiters 853
23.4 COMPETITIVE MARKET SHARE ANALYSIS 855

APPENDIX III: PERIPHERAL IVUS CATHETER MARKET 856


24.1 INTRODUCTION 856
24.2 MARKET ANALYSIS AND FORECAST 857
24.3 DRIVERS AND LIMITERS 860
24.3.1 Market Drivers 860
The Peripheral Vascular Devices Market Report Suite | Europe | 2020-2026 | MedSuite includes analysis on the following companies currently active in this market:

• Aachen Resonance GmbH.
• Boston Scientific
• Abbott Vascular
• C. R. Bard
• Acandis GmbH
• Cardinal Health
• ACIST Medical
• Cardionovum GmbH
• Acrostak
• Cardiovascular Systems Inc.
• Affluent Medical
• Cardiva
• AngioDynamics
• Celenova Biosciences Inc.
• Argon Medicalv
• Concept Medical
• Asahi Intecc
• Contego Medical
• Avimedica
• Control Medical Technology
• Avinger
• Cook Medical
• B. Braun
• Endospan
• BiO2
• Eurocor
• Biosensors International Group Ltd.
• Infraredx Inc.
• Biotronik
• InSeal Medical
• Biovic
• Invamed
• Blockade Medical
• Jotec

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology


close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link
close-link